Benjamin Graham · Inversión deep-value defensiva
Is Apellis Pharmaceuticals, Inc. (APLS) a Benjamin Graham Stock?
Meets 2/7 Graham criteria, classic deep-value candidate.
75/100
No encaja
2/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a APLS
P/E ≤ 15
clave38.8x
P/B ≤ 1.5
clave12.5x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
1.1x
Cómo se valora APLS en otras estrategias
Datos financieros en vivo
Cap. mercado
$5.25B
PER (TTM)
38.8x
ROIC (TTM)
18.11%
Margen bruto
90.12%
Otros análisis Benjamin Graham
Preguntas frecuentes
What is APLS's Benjamin Graham fit score?
APLS scores 75/100 on our Benjamin Graham fit engine. Meets 2/7 Graham criteria, classic deep-value candidate.
Does Benjamin Graham actually own APLS?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends APLS.
How often is this score updated?
APLS's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende APLS personalmente.
